|
US2015216849A1
|
|
Donepezil compositions and methods of treating alzheimers disease
|
|
US2015157575A1
|
|
Pharmaceutical Formulations Comprising Vilazodone
|
|
WO2015070131A1
|
|
Compositions and methods of treatment comprising fosfomycin disodium
|
|
US2014005395A1
|
|
4-(2-(6-substituted-hexylidene) hydrazinyl)benzonitrile and preparation thereof
|
|
US2013324724A1
|
|
Methods for the synthesis of 1,3-substituted aminouracils and other xanthine-related compounds
|
|
US2013210919A1
|
|
Novel crystalline forms of (1s,2r)-2-(amino methyl)-n,n-diethyl-1-phenyl cyclopropane carboxamide
|
|
WO2014031162A1
|
|
Crystalline form of carbamoyl-cyclohexane derivatives
|
|
US2014057954A1
|
|
Chemical composition
|
|
US2014018307A1
|
|
Linaclotide compositions
|
|
US2013172303A1
|
|
Roflumilast compositions for the treatment of copd
|
|
WO2011088331A1
|
|
Stable dosage forms of levomilnacipran
|
|
CN102781451A
|
|
Compositions and methods for treating bacterial infections using ceftaroline
|
|
CA2770334A1
|
|
Orally disintegrating compositions of linaclotide
|
|
EP2448953A1
|
|
Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thatreof as a2ar agonists
|
|
WO2010129689A1
|
|
Milnacipran formulations
|
|
WO2010127208A1
|
|
Inhibitors of acetyl-coa carboxylase
|
|
WO2010127212A1
|
|
Inhibitors of acetyl-coa carboxylase
|
|
WO2010075356A1
|
|
Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase
|
|
WO2010077915A1
|
|
Novel compounds useful as cc chemokine receptor ligands
|
|
WO2010068881A1
|
|
Novel benzodioxane and benzoxazine derivatives useful as cc chemokine receptor ligands
|
